[Dextran-therapy in diffuse (progressive) scleroderma].
D000328:Adult; D000368:Aged; D003911:Dextrans / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008365:Manometry; D008833:Microcirculation; D008875:Middle Aged; D008970:Molecular Weight; D010993:Plethysmography, Whole Body; D012595:Scleroderma, Systemic / Q000188:drug therapy*
D003911:Dextrans
Dextran-Therapie bei diffuser (progressiver) Sklerodermie.